Introduction 66
Upon viral entry, the HIV-1 core is released into the host cell cytoplasm and starts its journey 67 towards the nucleus (1, 2) helped or hampered by cellular factors (3) (4) (5) (6) (7) (8) (9) (10) . The viral core has a 68 conical shape (120nm x 60nm x 40 nm), detection of free cores in the cytoplasm, sections were labelled with anti-CA and a secondary 166 antibody coupled to 10nm gold particles (Fig. 2B ). Core like structures that had retained a 167 "quasi" conical shape were also seen in the vicinity of the nuclear envelope (NE). These CA-168 positive viral structures were usually decorated with 2 gold particles ( Fig. 2B -ii, -iii), 169
although the viral core is composed by multiple CA monomers. Uninfected cells labelled with 170 anti-CA and a secondary antibody labelled with gold particles revealed only background 171 labelling, showing the specificity of the antibody (Fig. 2B -i ). During and after the nuclear 172 viral entry, conical core like structures were not detected and instead the immuno-labelling 173 decorated a different CA-positive pattern (Fig. 2B ). On the cytoplasmic side of the nuclear 174 pore we could detect irregular shapes similar to "core like structures" decorated with anti-CA 175 . In the nucleus, however, the same antibody outlined pearl-necklace shapes, 176 composed by multiple CA proteins . Cytoplasmic viral complexes were 177 typically decorated by 2 CA gold particles (~ 80%) whereas the nuclear complexes were 178 labelled on average by 3 particles (Fig. 2C ). The detection of these particular nuclear CA 179 forms was not antibody dependent, because similar results were obtained with another 180 antibody against CA (AG3.0) ( Fig. 2D) . Importantly, the difference in gold distribution was 181 also seen with wild-type HIV-1 ( Fig. 2E ), implying that it did not depend on the route of viral 182 entry. By cryo-EM, we confirmed the presence of multiple CA gold particles forming a 183 "pearl necklace" shape inside the nucleus of infected cells ( Fig. 2F and G) . These elongated 184 CA complexes are better resolved by cryo-EM (47) and detected by more gold particles when 185 a protein A coupled to gold was used instead of a secondary antibody (Fig. 2F ). This likely 186 related to a better affinity of the protein A for primary antibodies compared to secondary 187 gold-conjugated antibodies. Importantly, different labelling methods labelled similar 188 structures in the nucleus and confirmed the increase in labelling after nuclear entry (Fig. 2B, 189 D, F and G). 190 Taken together, our data indicate that the viral core undergoes a morphological rearrangement 191 during nuclear entry coinciding with an increased CA-labelling by EM likely due to increased 192 accessibility of the antibody. 193
Discussion 299
HIV-1 core must undergo structural changes to be able to cross the NPC, as the pore is too 308 narrow to allow its passage as an intact core. Thus, the organization of viral CA complexes 309 during the early steps of HIV-1 infection is still unknown, due to the lack of appropriate tools 310 to study this event. Our study provides some new evidences on the viral remodelling of HIV-311 1 core occurring prior, during and after viral nuclear entry. Importantly we confirmed such 312 observation in the main physiological target cell of HIV-1, CD4+ T cells. We were able to 313 quantify a different distribution of CA gold labelling comparing cytoplasmic and nuclear 314 structures (Fig. 2C) , supporting a viral CA remodelling process during nuclear entry. We 315 observed that multilobe structures resembling to "core like shapes" can be labelled by 2 gold 316 particles, although the HIV-1 core is composed by ~1500 CA monomers (12, 57) . This can be 317 explained by specific features of EM immuno-labelling that is dependent on the specificity of 318 the antibody, accessibility and number of antigens on thin sections, amongst other factors 319 (58) . Intranuclear CA complexes were detected by more gold particles than the cytoplasmic 320 viral structures, which we believe is due to rearrangement of the viral CA ( Fig. 2B- iv,-v, F 321 and G) . It should be noted that so far the presence of multiple CA proteins inside the nucleus 322 of infected mitotic cells has never been reported. To confirm the detection of intranuclear 323 complexes, tomograms performed at 6 hours post infection revealed the formation of pearl 324 necklace shapes composed by multiple CA located in the nucleus F and G) . 325
Often these nuclear CA structures are associated to viral IN (Fig. 3A) . Importantly, similar 326 complexes composed by multiple CA and IN have been identified in HeLa cells and primary 327 lymphocytes, revealing the organization of the viral CA proteins also in the main target cells 328 of HIV-1 ( Fig. 3C ). Our results show that viral complexes observed during nuclear 329 translocation could represent PICs, thanks to the ability to combine the specific labelling of 330 the retrotranscribed DNA (HIV-1 ANCHOR) with immunogold CA labelling. So far the viral 331 DNA has never been visualized associated to multiple CA proteins in dividing infected cells. 332 Importantly, we observed that HIV-1 ANCHOR allowed the specific detection of the viral 333 DNA as shown by the use of drugs (Fig. 5 ). This is highlighted by using drugs that block 334 different steps of the HIV-1 early events, such as nuclear import (PF74 drug) or reverse 335 transcription (nevirapine) ( Fig 5) . Bright spots identifying viral DNA were prevalently 336 detected in the nucleus of untreated cells, in agreement with results obtained by real time PCR 337 that amplified 2LTR circles (Fig. 5B, C and D) , commonly used to detect viral nuclear import 338 (59). Thus, CLEM enabled to visualize the organization of HIV-1 PIC during nuclear 339 translocation in HIV-1-permissive cells. It should be noted that HIV-1 ANCHOR can 340 specifically label all nuclear viral DNA forms, thus, further experiments are needed to 341 distinguish integration competent viral complexes from dead-end products. Independently of 342 the fate of the PIC, HIV-1 ANCHOR technology combined with EM offered the opportunity 343 to observe how viral CA proteins reshape near the NPC to lead the viral genome in the 344 nucleus ( Fig. 6A and B ). OR-GFP can bind the viral DNA only if it is exposed, as indicated 345 by our CLEM results, which support our model of viral core remodelling. In fact, complexes 346 of multiple CA associated to the retrotranscribed DNA can be visualized by CLEM before 347 and during the nuclear translocation ( Fig. 6A and B) . Likely, the observed complexes contain 348 complete retrotranscribed genomes. In agreement with this observation, previous studies 349 showed that OR-GFP binds only dsDNA (60), meaning that the vDNA shrouded in the 350 multiple CA proteins complex is a dsDNA. The ANCH3 sequence has been cloned in place of 351 nef, which means that the vDNA identified by CLEM might be a late reverse transcript, since 352 OR-GFP can only bind it after the completion of reverse transcription on both strands 353 containing the ANCH3 sequence. Thus, all viral complexes carrying an accessible vDNA can 354 be observed by fluorescence microscopy. As opposed to fluorescence microscopy, the 355 visualization of viral complexes by EM coupled with gold labeling is more complicated, but 356 has the advantage of yielding high resolution images. Sections are not permeabilized, so only 357 CA epitopes exposed on the surface of the section can be labeled by the anti-CA antibody and 358 then by a secondary gold labeled antibody. Indeed, a limited number of available epitopes can 359 be recognized by the primary antibody in sections. The aforementioned reasons, together with 360 the thorough sample fixation required for the EM strictly limit the number of epitopes 361 accessible to the antibody. Apart from such technical limitations, we do not expect to have all 362 vDNA complexes co-labeled with CA, as a result of the asynchronous infection conditions 363 used and the consequent presence of some CA-free nuclear vDNA, as previously shown by 364
Brass group (30). Overall, these results indicate that the viral complexes visualized by CLEM 365 could potentially be PICs. 366
Summarizing, the viral CA reshapes before crossing the NPC, decorating the viral DNA and 367 leading it into the nucleus. Similar CA-viral DNA complexes can be also found inside the 368 host nuclei (Fig. 7) . 369
The presence of consistent shapes formed by multiple CA proteins in the nucleus D, F and G; Fig. 3A and C) , as well as their association to the retrotranscribed DNA (Fig. 371 6A and B; Fig. 7) , would indicate that these CA forms are imported with the viral genome 372 into the host nucleus. These results would support the evolution of the concept of viral 373 uncoating, no more seen as a complete loss of viral CA but as a CA remodelling during nuclear import. Another novel aspect of our work is the development of the HIV-1 375 ANCHOR system, the first fluorescence DNA labelling technique shown to be compatible 376 with TEM. This innovative technology allows us to follow the HIV-1 DNA shrouded by 377 multiple CA proteins during and after nuclear entry in mitotic cells. In addition, we were able 378 to live-track the viral DNA in the nucleus of infected cells following translocation through the 379 pore (suppl. movies 1,2,3,4). 380
Of note, our study gives new information on the early steps of HIV-1 infection in dividing 381 cells. It is known that mitotic cells with integrated viruses may persist for many years, 382 undergo clonal expansion (61). Clonal expansion seems to be the major mechanism to 383 generate HIV-1 reservoir (62) Cells. HeLaP4R5 cells, a HeLa-CD4/LTR-lacZ indicator cell line expressing both CXCR4 397 and CCR5, were employed to assess viral infectivity (64) using a beta gal assay. 293T cells 398 (ATCC) are human embryonic kidney cells used to produce lentiviral vectors and HIV-1 399 viruses, HeLa cells (ATCC) derived from cervical cancer cells. CD4 + T cells were isolated 400 from healthy donors obtained via the EFS (Etablissement Français du Sang, Paris, France). 401
Briefly, primary CD4 + T cells were purified from human peripheral blood by density gradient 402 centrifugation (Lymphocytes separation medium, PAA) followed by positive 403 immunomagnetic selection with CD4 Microbeads (Miltenyi). The day later cells were 404 activated by T Cell Activation kit (Miltenyi) for 2-3 days at 37°C with interleukin 2 (IL-2)-405 containing medium (50 IU/ml), then cells were challenged with HIV-1 carrying the CA wild 406 type or mutated. Percentage of p24 positive cells has been obtained cytofluorimetry 407 acquisition and FlowJo analysis. in Hi Q4 microdishes (10,000 cells per chamber) (Ibidi). The following day, cells were 422 infected with HIV-1ΔEnvIN HA Δ NefANCH3/VSV-G. Transmission and fluorescence images 423 were taken every 5 or 10 min for up to 96 h using a Nikon Biostation IMQ (40X objective) 424 with 6-8 fields captured simultaneously for each condition or for up to 24h by using a 425 spinning-disk UltraView VOX (Perkin-Elmer) (63x objective) with one field of view for 426 each experiment in 2D or 3D. Images were analyzed in FIJI or Imaris.
Western blotting and confocal immunoimmunofluorescence microscopy. The expression 428
of the correct size of the cDNA OR-GFP cloned in LV has been tested by western blotting. 429
Proteins were extracted on ice from wild type and LVOR-GFP transduced HeLa cells using 430 RIPA buffer (20mM HEPES pH 7.6, 150mM NaCl, 1% sodium deoxycholate, 1% Nonidet P-431 40, 0.1% SDS, 2mM EDTA, complete protease inhibitor (Roche Diagnostics)), and protein 432 concentration was quantified using the Dc Protein Assay (Bio-Rad Laboratories) with BSA as 433 standard. Ten micrograms of total protein lysate was loaded onto SDS-PAGE 4-12% Bis Tris 434 gels (Invitrogen). Revelation was carried out using the ECL Plus western blotting kit (GE 435 Healthcare). Primary antibody used for western blotting (WB) was anti-GFP (Clontech 436 #632592, dilution 1:1000). Secondary conjugated antibodies used for western blotting were 437 Beta Actin HRP conjugated antibody (Abcam, #8226 1:2,500), and anti-rabbit IgG HRP 438 (sc2357 Santa Cruz). Immunofluorescence microscopy: HeLa P4R5 cells stably expressing 439 OR-GFP or not were plated onto 12 mm diameter coverslips in 24-well plates the day before 440 and then infected with HIV-1ΔEnvIN HA Δ Nef ANCH3/VSV-G or HIV-1ΔEnvIN HA /VSV-G 441 at different MOIs and different time post infection. The cells were then washed, fixed with 442 4% PFA, permeabilized with Triton X 100 0.5% for 30 min and blocked with 0.3% bovine 443 serum albumin (BSA). All incubations were carried out at room temperature and were 444 followed by five PBS washes. Cells were incubated with primary antibodies for 1 h and 445 secondary antibodies for 30 min. Antibodies were diluted in 0.3% BSA. Nuclei were stained 446 with Hoechst (Invitrogen, dilution 1:10000). Finally, cells were mounted onto glass slides 447 (Thermo Scientific) with Prolong Diamond (Life Technologies). Confocal microscopy was 448 carried out on a Zeiss LSM700 using a 63× objective. Representative medial sections or 449 combined Z stacks are shown as indicated. Images were analyzed in FIJI. 450 451 Viral infection and sample preparation for electron microscopy. Eight million of HeLa 452 P4R5 or Hela P4R5 OR-GFP transduced cells were seeded in a T75 flask and infected with 453 4000ng of p24 of either HIV-1 IN-HA or HIV-1 ANCH3 and incubated for 6h. When a WT 454 virus has been used to infect HeLa P4R5 cells or primary CD4 + T cells a ultracentrifuged 455 virus has been used in some cases in presence of SEVI according a published protocol (65, 456 66) (SEVI fibrils have been kindly provided by Franck Kirchhoff). Infectivity has been 457 analysed by beta gal assay or by FACS. Samples were prepared for EM as follows: cells were 458 fixed by adding directly an equal volume of 8% paraformaldehyde, 0.2% glutaraldehyde in 459 PHEM buffer (60mM Pipes, 25mM Hepes, 2mM MgCl 2 , 10mM EGTA, pH 7.3) solution to 460 the cells medium and incubated for 30 minutes. Next, the solution was exchanged by 4% 461 paraformaldehyde diluted in PHEM buffer and incubated for 2 hours at room temperature. 462
Cells were further prepared for cryomicrotomy and immunolabelled as described in (67) Photonics). Then the grids were recovered by pouring 10ul of water underneath them. Grids 473 were washed contrasted and prepared for TEM as specified above. For the cryo-EM 474 observation the samples were prepared as described above. After immunolabelling the grids 475 were embedded with a mixture of 50% methylcellulose 2% and 50% sucrose 2.3M and then 476 vitrified by plunge freezing with EMGP plunge freezer (Leica) at 30 °C and 90% humidity. 477
478
Electron microscopy data collection and image processing. Sections, at room temperature 479 or in cryo, were transferred and imaged in a Tecnai T12 transmission EM operating at 120 or 480 80kV equipped with a Gatan Ultrascan 4000 camera. Multiscale mapping and tilt series 481 acquisitions in areas of interest were processed by a Serial EM software(68). In case of cryo 482 samples, low dose conditions and bi-directional tilt schemes were used during acquisition. 483
Tilt series stacks were initially aligned using cross-correlation and the alignments were further 484 refined using the immunogold beads as registration fiducials in IMOD (69). Tomograms were 485 reconstructed with the weighted back-projection method and filtered to assist manual 486 segmentation with IMOD. 487
The correlation between fluorescence and electron microscopy were achieved using the 488 following protocol: 1) z-stacks of every frame of the mosaic was projected with the FIJI's 489 plugin extended depth of field(70); 2) the frames were aligned and blended to generate a 490 fluorescence map of the complete section using Mosaic J (71); 3) the same cells was 491 identified in both fluorescence and low resolution TEM section map; 4) the high precision 492 correlation was obtained by identifying Tetraspecks positions in high resolution fluorescence 493 and TEM images using ec-CLEM plugin (56) of Icy (55).).
495
Quantitative PCR. Total cellular DNA was isolated using the QIAamp DNA micro kit 496 (QIAGEN) at 7 and 24 h post infection. The genomic DNA was treated for 1h at 37 ºC with 497 Dpn1. Ten micromolar of nevirapine was used in infected cells as control of the experiment. 498
Late reverse transcription products at 7 h post infection were measured by real-time PCR 499 using primers and probe previously described (59), 2LTR containing circles were detected 500 using primers MH535/536 and probe MH603, using as standard curve the pUC2LTR plasmid, 501 which contains the HIV-1 2LTR junction. Integration was assessed by Alu-PCR, using 502 primers designed in the U3 region of LTR (4) which is deleted in the LVs carrying OR-GFP 503 but not in the LTR of HIV-1 used to challenge OR-GFP stably expressing cells and control 504 cells. The standard curve has been prepared as follows: DNA generated from infected cells 505 was end point diluted in DNA prepared from uninfected cells and serial dilutions were made 506 starting from 50,000 infected cells. Each sample amplified contained 10,000 infected cells 507 mixed at 40,000 uninfected cells. The control of the first round PCR was the amplification 508 without Alu primers but only U3 primers (4). Dilutions 1:10 of the first round were amplified 509 We wish to thank Philippe Souque, François Anna and Olivier Gourgette for experimental 668 help, Fabrizio Mammano, Nicoletta Casartelli and Franck Gallardo for scientific discussion 669
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